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Objective: To determine the prevalence, genetic relatedness, and pattern of antimicrobial
susceptibility in methicillin-resistant Staphylococcus aureus (S. aureus) (MRSA) isolated
from household dogs, farm dogs, and stray dogs, compared to isolates from their asso-
ciated personnel.
Methods: MRSAwas isolated from 250 nasal swabs (150 swabs from dogs and 100 swabs
from humans). PCR assays were used to detect the presence of both the nuc andmecA genes,
which conﬁrmed the identity of S. aureus isolates and the presence of methicillin resistance,
respectively. Disk diffusion was used to determine the antibiotic susceptibility against 15
antimicrobial agents along with an E-test that determined the minimum inhibitory concen-
tration for oxacillin. Pulsed ﬁeld gel electrophoresis was conducted to determine the genetic
relatedness ofMRSA isolates from dogs to those from associated and unassociated personnel.
Results: The prevalence of S. aureus in dogs and humans was 12.7% and 10.0%
respectively, while the prevalence of MRSA isolates in dogs and humans was 5.3% and
5.0%, respectively. The prevalence of MRSA isolates in household dogs, farm dogs, and
stray dogs was 7.8%, 4.7%, and 0.0%, respectively. MRSA isolates demonstrated a
signiﬁcantly higher rate of multi-resistance against three or more antimicrobial agents
than methicillin-susceptible S. aureus (MSSA). Trimethoprim-sulphamethoxazole and
chloramphenicol were the most effective antibiotics against all MRSA isolates. Pulsed
ﬁeld gel electrophoresis revealed a strong association between dog MRSA isolates and
MRSA isolates from strongly associated personnel.
Conclusions: MRSA is prevalent in house dogs, as well as in dog rearing centers and
among their strongly associated personnel. A strong association was found between the
MRSA isolates from dogs and those from humans who are in close contact. In addition,
MRSA isolates showed a high rate of multi-resistance compared to MSSA isolates.1. Introduction
Methicillin-resistant Staphylococcus aureus (S. aureus)
(MRSA) is amajor health care-associated pathogenworldwide and
has increased in incidence dramatically over the last decade [1,2].
Companion animals have been implicated more frequently aspotential reservoirs of MRSA than other livestock [3,4]. In several
studies, a 0%–4% prevalence rate of MRSA in dogs has been
reported [5–7]. Other reports demonstrated MRSA at a higher
prevalence (~9%) in pets and veterinary staff [8,9], and the nasal
carriage of MRSA plays a key role in the epidemiology and
pathogenesis of community-associated infections [10,11].
In Jordan, MRSA is widely prevalent in Jordanian hospitals
and represents a serious public health problem. The nasal car-
riage rate of S. aureus among the Jordanian healthy young
population was 40%, and 19% of the nasal S. aureus, and 57%
of clinical isolates were resistant to oxacillin [12]. A retrospective
study conducted at King Abdullah University Hospital in North
Jordan showed that 152 S. aureus isolates collected from
different infections revealed that the overall rate of MRSAan open access article under the CC BY-NC-ND
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unit [13]. To our knowledge, no studies on MRSA in
companion animals in Jordan were found in the literature that
demonstrated its prevalence and health hazard. Therefore, this
study was conducted to document the prevalence of MRSA in
dogs and their associated personnel, as well as to determine
their genetic relatedness and antimicrobial resistant proﬁle.
2. Materials and methods
2.1. Sample collection, transportation, and preparation
In total, 250 nasal swabswere collected from 150 dogs and 100
humans during a period between March and the end of October
2009. The 150 dog samples were collected from household dogs,
stray dogs, and farm dogs from the middle and northern parts of
Jordan. The total numbers of household dogs, stray dogs, and farm
dogs were 77, 30, and 43, respectively, as illustrated in Table 1.
The 100 human nasal swab samples were collected from
personnel strongly associated with dogs (5 from dog owners, 50
from employees who feed, take care of, treat, and train dogs daily
at the Spana Welfare Center, Humane Center for Animal Welfare,
and K-9 Center, 25 from intermediately associated personnel,
including veterinarians working in clinics and veterinary students,
and 20 from unassociated personnel who have never been in
contact with dogs). A sterile cotton swab moistened with normal
saline was inserted into the nares and gently rotated to make
contact with the nasal septum. For dogs, smaller swabs were
inserted to a distance of about 0.5–1.0 cm. All swabs were placed
in a transport medium and stored at 4 C until cultured within 6-h
collection at the Microbiology Research Laboratory, Faculty of
Veterinary Medicine, Jordan University of Science and
Technology.
2.2. Isolation and identiﬁcation of S. aureus
All nasal swabs were cultured on mannitol salt agar (Oxoid,
UK) and incubated aerobically at 37 C for 24–48 h. The cultures
were then examined for the presence of S. aureus (yellow col-
onies) and for a microscopic appearance after Gram staining. The
presumptive S. aureus isolates were further examined for pig-
ments and coagulase production, by using the tube method [14].Table 1
Distribution of the dogs' nasal swab samples according to the dogs’
locations and type of rearing system in Jordan.
Middle zone Household
dogs
Stray
dogs
Farm
dogs*
Amman governorates
Swelieh city 5 4 6
Jaweh town 0 5 5
Sahaab town 0 6 7
Spana Welfare Center 13 0 0
Dogs Police K-9 Center 27 0 0
Humane Center for Animal Welfare 14 0 0
Al-Zarga governorates 0 4 8
Northern zone
Ramtha dogs Police K-9 Center 18 0 0
Jarash governorates 0 4 6
Ajlune governorates 0 3 4
Irbid governorates 0 4 7
Total 77 30 43
*: Dogs kept with sheep and goat ﬂocks.2.3. Molecular identiﬁcation of S. aureus isolates
2.3.1. DNA extraction and identiﬁcation of the nuc gene
The extraction protocol was done according to the Wizard
genomic DNA puriﬁcation kit (Promega cooperation, Technical
manual genomic DNA puriﬁcation part TM0580,Madson, USA).
Then, presumptive S. aureus isolates were tested by PCR ampli-
ﬁcation of the nuc gene [15]. PCR ampliﬁcation was conducted at a
ﬁnal volume of 25 mL [12.5 mL of Go Taq master mix (Promega,
USA), 5 mL (2.5 pmol) of each primer F (GCGATTGATGGTGA
TACGGTT) as well as R (AGCCAAGCCTTGACGAACT
AAAGC), 2.5 mL of a bacterial DNA sample and 5 mL nuclease
free water]. The PCR ampliﬁcation was conducted as follows:
5 min at 94 C, 35 cycles for 30 s at 94 C, 45 s at a
corresponding annealing temperature of 55 C, and 45 s at
72 C, and a ﬁnal extension of 10 min at 72 C. The PCR
products were observed on 1.5% agarose gels.
2.4. Identiﬁcation of MRSA by E-test and antimicrobial
susceptibility testing
MRSA isolates were identiﬁed by E-test (Oxoid, UK), which
is a gradient antibiotic stabilized on a plastic strip with 30
graduations to provide an accurate minimum inhibitory con-
centration (MIC) over a range of 256–0.015 mg/mL. This test
was conducted for oxacillin only, according to the manufac-
turers’ instructions (Oxoid, UK) and guidelines. Mueller-Hinton
agar (Difco, Detroit, MI, USA) supplemented with 2% NaCl was
used for this purpose [16]. Samples for the E-test were prepared
according to Clinical and Laboratory Standards Institute [17].
Isolates showed MICs equaled to or greater than 4 mg/mL,
which were considered MRSAs [18].
The agar disk diffusion susceptibility test of 15 antimicrobials
[cefoxitin (10 mg), penicillin (10 IU), cephalexin (30 mg), kana-
mycin (30 mg), gentamicin (10 mg), tobramycin (10 mg), amikacin
(30 mg), ciproﬂoxacin (5 mg), azithromycin (15 mg), erythromycin
(15 mg), tetracycline (15 mg), amoxicillin-clavulanic acid (20/
10 mg), trimethoprim-sulphamethoxazole (1.25/23.75 mg), nali-
dixic (30 mg), and chloramphenicol (30 mg)] was carried out by
using the Clinical and Laboratory Standard Institute guidelines
[19]. The S. aureus ATCC 25923 strain was used as a control.
2.5. Molecular identiﬁcation of MRSA
For further conﬁrmation, MRSA isolates were tested by PCR
ampliﬁcation of the mecA gene. PCR ampliﬁcation was conducted
at aﬁnal volumeof 25mL [12.5mLofGoTaqmastermix (Promega,
USA), 5 mL (2.5 pmol) of each primer F (50-GCAATCGCTAAA
GAACTAAG) as well as R (50-GGGACCAACATAACCTAA
TA) [20], 2.5 mL of a bacterial DNA template and 5 mL nuclease free
water]. PCR ampliﬁcation was conducted as follows: denaturation
at one cycle of 94 C for 3min, 30 cycles at 94 C for 45 s, annealing
at 53 C for 2 min, extension at 72 C for 30 s, and a ﬁnal extension
at 72 C for 5 min. The PCR products were observed by
electrophoresis on 1.5% agarose gels (Nusieve Bioproducts,
Maine, USA).
2.6. Pulsed ﬁeld gel electrophoresis (PFGE)
PFGE was used to study the genetic relatedness between the
S. aureus isolates from dogs and human S. aureus isolates.
PFGE was performed according to a Canadian standard protocol
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done with a CHEF-DR III apparatus (Bio-Rad, USA) by using
the auto-algorithm program and switch times of 5.3–34.9 for
18 h at a 6.0 V/cm gradient and 14 C in 0.5 mL Tris-Borate-
EDTA. The gel was stained for 20 min with 0.5 mg of
ethidium bromide per liter and destained with Millipore-ﬁltered
H2O for at least 30 min with water changes for three times.
PFGE gels were viewed under ultraviolet light.
2.7. Data analysis
Gels were photographed and digitized with the FOTO/Analyst
Archiver system, and an analysis with BioNumerics version 2.0
software was conducted (Applied Maths, Belgium). The S. aureus
ATCC 43300 and ATCC 25923 strains were used as reference
standards for MRSA and methicillin-susceptible S. aureus
(MSSA), respectively. A Wilcoxon test (paired) was used to
compare the antibiotic susceptibility of MRSA and MSSA isolates
against different antimicrobial agents, and it was also used to
compare the MICs of MRSA and MSSA isolates against oxacillin.
3. Results
3.1. Conventional and molecular identiﬁcation of
S. aureus
In total, 46 isolates were conﬁrmed as Staphylococci; among
them, 29 isolates (19 from dogs and 10 from humans) wereFigure 1. Agarose gel electrophoresis of PCR products (nuc gene).
Lane M: DNA molecular marker (100 bp); Lane +ve: Positive control
(S. aureus ATCC 25923); Lane -ve: Negative control (water); Lanes 33, 34,
35, 36, 37: Positive samples showing the 270 bp gene product; Lanes 31,
32, 38, 39, 40, 41, 42, 43: Negative samples.
Table 2
Antibiotic resistance pattern of 13 methicillin resistant and 16 susceptible S.
Antibiotics MRSAr
R I
Cefoxitin 13 (100) 0
Penicillin 12 (92) 1 (8)
Cephalexin 3 (23) 1 (7)
Kanamycin 3 (23) 0
Gentamicin 3 (23) 0
Tobramycin 3 (23) 1 (7)
Amikacin 3 (23) 2 (15)
Ciproﬂoxacin 3 (23) 0
Azithromycin 2 (15) 0
Erythromycin 7 (54) 1 (7)
Tetracycline 5 (39) 2 (15)
Amoxicillin-clavulanic acid 6 (46) 0
Trimethoprim-sulphamethoxazole 0 0
Nalidixic 9 (69) 1 (7)
Chloramphenicol 0 0
r,s: MRSA are signiﬁcantly resistant to the tested antibiotic than MSSA (Pconventionally identiﬁed as S. aureus and conﬁrmed by ampli-
fying the thermonuclease gene (nuc) using PCR (Figure 1). The
prevalence rate of S. aureus in dogs was 12.7% (19/150) and in
humans, it was 10% (10/100).
3.2. MRSA and susceptibility test
Out of 29 S. aureus strains, 13 were MRSA; among them, 8
were from dogs (prevalence rate was 5.3%) and 5 were from
humans (prevalence rate was 5.0%). Six MRSA isolates were
from 77 household dogs [one from each of the Swelieh city,
Spana Welfare Center, Humane Center for Animal Welfare, and
K-9 Center/Ramtha and two from the K-9 Center/Amman
(prevalence rate was 7.8%)]. The other two MRSA isolates were
isolated from 43 farm dogs from the Al-Zarqa and Irbid gov-
ernorates (prevalence rate was 4.7%). No MRSA was isolated
from stray dogs. One human MRSA isolate was from a dog
owner whose dog had MRSA, and the other four MRSA isolates
were from strongly associated personnel (two from K-9, one
from Spana Welfare Center, and one from Humane Center for
Animal Welfare).
All MRSA isolates were found to be resistant to cefoxitin. In
contrast, all MRSA isolates were susceptible to trimethoprim-
sulphamethoxazole and chloramphenicol. MRSA was also
found to be susceptible to azithromycin, cephalexin, amino-
glycoside, kanamycin, gentamicin, tobramycin, and amikacin in
a range of 62%–85%. The antibiotics resistant to all MRSA and
MSSA isolates are shown in Table 2, and the MRSA isolates
were found to be signiﬁcantly more resistant to the tested anti-
biotic than MSSA isolates (P < 0.001). In addition, the MRSA
isolates of humans were signiﬁcantly more resistant than the
MRSA isolates of dogs against erythromycin, tetracycline, and
amoxicillin-clavulanic acid (Table 3).
3.3. MIC
An E-test was used to evaluate the MIC of oxacillin. Out of
29 S. aureus isolates, all MRSA (13) isolates showed oxacillin
resistance (oxacillin MIC  4 mg/mL).
In addition, MRSA MICs were signiﬁcantly higher than
MSSA MICs in both humans and dogs (P  0.001), and MRSAaureus isolates. n (%).
MSSAs
S R I S
0 1 (6) 1 (6) 14 (88)
0 3 (19) 2 (13) 11 (69)
9 (70) 1 (6) 1 (6) 14 (88)
10 (77) 2 (13) 2 (13) 12 (75)
10 (77) 1 (6) 1 (6) 14 (88)
9 (70) 1 (6) 1 (6) 14 (88)
8 (62) 2 (13) 2 (13) 12 (75)
10 (77) 0 2 (13) 14 (88)
11 (85) 0 1 (6) 15 (94)
5 (39) 2 (13) 2 (13) 12 (75)
6 (46) 2 (13) 3 (19) 11 (69)
7 (54) 2 (13) 0 14 (88)
13 (100) 0 0 16 (100)
3 (23) 3 (19) 2 (13) 11 (69)
13 (100) 1 (6) 1 (6) 14 (88)
< 0.001); R: Resistant; I: Intermediate; S: Susceptible.
Table 3
Comparison of antibiotic resistance pattern of 8 MRSA isolates from dogs and 5 MRSA from humans. n (%).
Antibiotics MRSA in dogs MRSA in humans
R I S R I S
Cefoxitin 8 (100) 0 0 5 (100) 0 0
Penicillin 5 (63) 1 (12) 2 (25) 3 (60) 0 2 (40)
Cephalexin 2 (25) 0 6 (75) 1 (20) 1 (20) 3 (60)
Kanamycin 3 (37) 0 6 (75) 2 (40) 0 3 (60)
Gentamicin 1 (12) 0 7 (88) 2 (40) 0 3 (60)
Tobramycin 2 (25) 1 (12) 5 (63) 1 (20) 0 4 (80)
Amikacin 0 2 (25) 6 (75) 2 (40) 0 3 (60)
Ciproﬂoxacin 0 0 8 (100) 3 (60) 0 2 (40)
Azithromycin 1 (12) 0 7 (88) 1 (20) 0 8 (80)
Erythromycin 3 (37)S 0 5 (67) 4 (80)S 1 (20) 0
Tetracycline 2 (25)S 1 (12) 5 (67) 3 (60)S 1 (20) 1 (20)
Amoxicillin-clavulanic acid 2 (25)S 0 6 (75) 3 (60)S 0 2 (40)
Trimethoprim-sulphamethoxazole 0 0 8 (100) 0 0 5 (100)
Nalidixic 5 (63) 1 (12) 2 (25) 4 (80) 1 (20) 0
Chloramphenicol 0 0 8 (100) 0 0 5 (100)
S: Signiﬁcant difference (P < 0.001); R: Resistant; I: Intermediate; S: Susceptible.
Table 4
MIC of MRSA and MSSA isolates in dogs and humans against oxacillin
by E-test. mg/mL.
Sample code MRSAr MICs Sample code MSSAr MICs
D8 8r1 D14 0.250
D9 6 D19 0.500
D20 6 D23 2.000
D58 16 D28 0.012
D71 6 D53 1.000
D82 8 D61 1.000
D143 12 D66 0.060
D147 16 D92 1.000
H34 8r1 D103 0.500
H37 32 D109 0.120
H92 48 D137 0.030
H15 8 D84 2.000
H13 6 H25 0.500
H67 0.120
H73 1.000
H76 0.500
r: MRSA MICs are signiﬁcantly higher than MSSA MICs in both human
and dogs (P < 0.001); r1: MRSA MICs are signiﬁcantly higher in
humans than MRSA MICs in dogs (P < 0.001).
Figure 2. Agarose gel electrophoresis of PCR products (mecA gene).
Lane M: DNA molecular marker (100 bp); Lane +ve: Positive control
(S. aureus ATCC 43300); Lane -ve: Negative control (S. aureus ATCC
25923); Lanes 16, 19, 20, 21, 22, 25, 26: Positive samples showing the
222 bp gene product; Lanes 14, 15, 17, 18, 23, 24: Negative samples.
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dogs (P  0.001), as shown in Table 4.
3.4. PCR for the identiﬁcation of the mecA gene
The results of PCR showed that 13 (45%) of 29 S. aureus
isolates were positive for the presence of the mecA gene
(Figure 2). Five MRSA isolates were from humans and eight
were from dogs.
3.5. PFGE
The SmaI macrorestriction fragment proﬁles of 29 S. aureus
isolates were determined by PFGE (Figure 3). A dendrogram of
a percent similarity and DNA relatedness were calculated based
on the Dice coefﬁcient, which revealed ﬁve major clusters of
isolates: Jordan A, Jordan B, Jordan C, Jordan D, and Jordan E
(Figure 4). All isolates are grouped into the above-mentioned
ﬁve clusters, as shown in Table 5.Figure 3. Results of PFGE gel of SmaI macrorestriction fragments of dog
and human S. aureus isolates.
Lane M: DNA molecular marker (100 bp); Lane 1: Positive control of
MRSA (S. aureus ATCC 43300); Lane 2: Positive control of MSSA
(S. aureus ATCC 25923): Lanes 3 to 13: S. aureus isolates; M: Molecular
sizes.
Figure 4. A PFGE dendogram of 29 S. aureus isolates collected from
humans and dogs in Jordan with positive control of MRSA and non-
MRSA.
JA: Jordan A cluster; JB: Jordan B cluster; JC: Jordan C cluster; JD: Jordan
D cluster; JE: Jordan E cluster.
Table 5
Groups of the 29 S. aureus isolates in different clusters determined by
PFGE dendogram.
Clusters S. aureus groups
MRSA/dogs MRSA/humans MSSA/dogs MSSA/humans
Jordan A 3 1 4 0
Jordan B 2 1 2 0
Jordan C 0 0 2 2
Jordan D 2 2 3 3
Jordan E 1 1 0 0
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In this study, the prevalence of the S. aureus nasal carriage
isolates in dogs was 12.7% and of MRSA, it was 5.3%. To the
best of our knowledge, this is the ﬁrst report about the nasal
carriage of S. aureus and MRSA in dogs in Jordan. The
S. aureus nasal carriage of dogs in Jordan is more prevalent than
8.8% which was reported in a Hong Kong study [22], similar to
the other study in Austria [23]. The human nasal carriage rate was
10%, which is similar to other reports in Jordan [11], but it is not
in agreement with others [12], which reported a 40% nasal
carriage rate in Jordan. However, the variable in the nasal
carriage of S. aureus may be different due to populations,
geographical locations, and the inﬂuence of genetic and
environmental factors [10]. In addition, the cell-wall lip-
oteichoic acid, hormonal status, and antimicrobial activity of
nasal secretions play a role [24].In this study, the prevalence rate of MRSA in dogs was 5.3%
and most dogs carrying MRSA are either household dogs or
reared at rearing centers (prevalence rate was 7.9%), where they
are exposed daily to close contact with their personal associates. In
contrast, stray dogs did not have MRSA, and this could be
explained by that those dogs are not exposed to the human pop-
ulation and do not receive veterinary care. Two MRSA isolates
were from farm dogs and a study may be needed to demonstrate
the prevalence of MRSA in farm animals in Jordan. The MRSA
prevalence in dogs was similar to other studies [7,8,25].
The MRSA nasal carriage rate in humans was 5%, and that
represents 50% of the 10 S. aureus strains isolated from 100
human nasal swabs, which may be explained by daily close
contact with dogs that transmit MRSA between owners and
personnel strongly associated with dogs easily. It may also be
due to the continued use of antibiotics [9,22,26]. The close contact
between household pets and humans offers favorable conditions
for the transmission of MRSA by direct contact (petting, licking,
and physical injuries) or through the domestic environment
(contamination of food, water, and plates) and physical contact
with dogs, as well as through contact with household
environments contaminated by pets (ﬂoors, furniture, and
carpets) [27].
In the current study, the oxacillin resistance in human isolates
was signiﬁcantly higher than that in dog isolates. This may
indicate the unwise use of antibiotics in humans, wherein people
obtain antibiotics without a prescription. In other countries, this
is not always the case, as a higher oxacillin resistance in canine
isolates compared to that in human isolates was reported [22].
The present investigation also demonstrated MRSA isolates
were signiﬁcantly more resistant to the tested antibiotics than
those of MSSA. However, all MRSA isolates were susceptible
to trimethoprim-sulphamethoxazole and chloramphenicol. The
results of the current work showed similar ﬁndings to that of Al-
Zu'bi et al. [12], where all nasal isolates were susceptible to
chloramphenicol, while clinical isolates showed some resistance.
In the current study, the MRSA isolates showed 92% resis-
tance to penicillin, which is similar to another study in Jordan
that showed all human MRSA isolates were resistant to peni-
cillin and 23% of MRSA isolates were resistant to cephalexin,
which is not in agreement with other reports [11,28]. MRSA in the
current study showed 23% resistance to aminoglycoside,
gentamicin, kanamycin, tobramycin, and amikacin, in contrast
to the studies of others where higher resistance to kanamycin
(98%), tobramycin (97%), and amikacin (89%) was reported
[11,28,29]. In total, 77% and 23% of MRSA isolates were
susceptible to ciproﬂoxacin and nalidixic acid, respectively,
which is not in agreement with other reports that demonstrated
100% and 93% of MRSA isolates were susceptible to
ciproﬂoxacin and nalidixic acid, respectively [9,11]. The MRSA
in the current work revealed a 54% resistance to erythromycin,
which is in agreement with other reports [11,28,30]. The MRSA
susceptibility to tetracycline was 46%, which is not in
agreement with other studies that reported all MRSA isolates
were susceptible to tetracycline [9,11]. The lowest resistance
was observed against azithromycin (15%) and 46% of MRSA
isolates were resistant to amoxicillin-clavulanic acid, which is
in contrast with another study in Korea, wherein 97% and 98%
of MRSA isolates were resistant to azithromycin and
amoxicillin-clavulanic acid, respectively [29]. Gentamicin,
ciproﬂoxacin, azithromycin, amoxicillin-clavulanic acid, and
tetracycline are human medicines, and the emergence of strains
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health risk of MRSA.
The resistance patterns of MSSA are signiﬁcantly less than
those of MRSA (P < 0.001), except for trimethoprim-
sulphamethoxazole, which is similar. All MSSA isolates were
susceptible to all antimicrobial agents tested in this study in a
range of 69%–100%, and this is in agreement with another study
wherein multi-drug resistance was found to be less common
amongst MSSA isolates [30]. In the current study, the MSSA
isolates showed no resistance to ciproﬂoxacin, azithromycin,
or trimethoprim-sulphamethoxazole, followed by aminoglyco-
side and chloramphenicol. These results are similar to the ﬁnd-
ings of another report in India and are in contrast to the results of
a UK study that stated all MSSA isolates were susceptible to
gentamicin and tetracycline [30,31].
The discrepancies ofMRSAantibiotic susceptibility resultsmay
be due to the use of different methods for susceptibility testing,
different breakpoints for the evaluation of the results, and the
misuse of antimicrobial agents, resulting in microbial ﬁtness [27].
Two of ﬁve human MRSA isolates showed signiﬁcantly
higher oxacillin MICs than those in dog MRSA isolates
(Table 4). This may be due to the high and uncontrolled use of
antimicrobial agents in human medicines in Jordan. In addition,
the authors’ observations indicated that dogs included in this
study were less exposed to antimicrobial treatment. In case of
MRSA with oxacillin MIC 8 mg/mL, multiple-drug resistance
was observed.
PFGE revealed ﬁve major clusters designated as pulsed-ﬁeld
types: Jordan A, Jordan B, Jordan C, Jordan D, and Jordan E.
These clusters showed a percentage of similarities among
different isolates. Isolates in clusters Jordan A, Jordan B, Jordan
D, and Jordan E showed that the genetic relatedness between
dog and human MRSA isolates were as follows. In cluster
Jordan A, the relatedness between MRSA isolates from dogs and
those from humans was 80%–90%, and in clusters Jordan B and
Jordan E, the relatedness was 100%. In cluster Jordan D, the
relatedness was 80%–90%. This may be because most human
and dog MRSA isolates were collected from the same rearing
centers where dogs and personnel are in daily close contact for
months or even years. MRSA isolates in the Jordan E cluster are
from one dog and his owner in Swelieh city. These results agree
with other study ﬁndings that MRSA isolate relatedness is high
when dogs and humans share the same place [32]. The MRSA
isolates from either dogs or humans shared mostly similar
antibiotic resistance patterns, and this agreed with another
study [32]. Based on these data, we assume that the dogs are
colonized with the same strain or clone as their owners or
strongly associated personnel. This is in agreement with other
reports about the possibility of MRSA transmission between
dogs and humans [3,9,32,33]. The current study concludes and
conﬁrms the presence of MRSA in the nasal cavities of dogs,
dog owners, and personnel strongly associated with dogs in
Jordan, and that MRSA is highly prevalent in household dogs
rather than in stray dogs. A genetic relatedness among the
MRSA isolates of dogs and those of humans was
demonstrated, suggesting a strong possibility of MRSA
transmission between them, and MRSA isolates showed a high
rate of multi-resistance compared to MSSA isolates.
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